Hybrid inhibitors of DNA and HDACs remarkably enhance cytotoxicity in leukaemia cells-Reference-Cited by-同舟云学术

Hybrid inhibitors of DNA and HDACs remarkably enhance cytotoxicity in leukaemia cells

Published:2020-01-01 Issue:1 Volume:35 Page:1069-1079
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Song Yoojin¹,Park Sun You¹,Wu Zhexue²,Liu Kwang-Hyeon²^ORCID,Seo Young Ho¹

Affiliation:

1. College of Pharmacy, Keimyung University, Daegu, Republic of Korea

2. BK21 Plus KNU Multi-Omics based Creative Drug Research Team, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, South Korea

Funder

Ministry of Education

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2020.1754812

Reference53 articles.

1. DNA damage-induced cell death by apoptosis

2. DNA repair dysregulation from cancer driver to therapeutic target

3. DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics

4. Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas

5. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSE1L Silencing Enhances Cytarabine-mediated Cytotoxicity in Acute Myeloid Leukemia;Indian Journal of Hematology and Blood Transfusion;2024-05-27

2. Hydroxamic acid hybrids: Histone deacetylase inhibitors with anticancer therapeutic potency;European Journal of Medicinal Chemistry;2023-12

3. Chlorambucil-Bearing Hybrid Molecules in the Development of Potential Anticancer Agents;Molecules;2023-09-30

4. Acute Myeloid Leukemia Secondary to Chronic Lymphocytic Leukemia After Prolonged Chlorambucil Therapy: A Case Report;Pharmacogenomics and Personalized Medicine;2023-04

5. Development of Non-Ethoxypropanoic Acid Type Cryptochrome Inhibitors with Circadian Molecular Clock-Enhancing Activity by Bioisosteric Replacement;Pharmaceuticals;2021-05-24